Jiyan Liu

We track 2 ClinicalTrials.gov studies led by Jiyan Liu. The portfolio skews toward Phase 2 (1 trials).

2 clinical trials sponsored by Jiyan Liu.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
50%
Phase 1 1
50%

Trial Status Breakdown

Trials by Jiyan Liu

Neoadjuvant Therapy With EGFR-ADC (Becotatug Vedotin) Combined With PD-1 Inhibitor (Pucotenlimab) for Penile Squamous Cell Carcinoma With Penile Preservation Difficulty or Regional Lymph Node Metastasis: A Single-Arm, Phase II Clinical Trial

NCT07518979 · NOT YET RECRUITING · Phase 2

MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinoma: A Prospective, Single-Arm, Phase I Clinical Trial

NCT07054307 · RECRUITING · Phase 1

Frequently Asked Questions

How many clinical trials does Jiyan Liu sponsor?

Jiyan Liu currently sponsors 2 clinical trials tracked on ReadTheTrial. These span Phase 2, Phase 1.

What conditions does Jiyan Liu research?

Jiyan Liu conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Jiyan Liu recruiting for clinical trials?

Yes, Jiyan Liu currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More